Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LTC004 / Leto Laboratories
LTC004-01, NCT06255912: Clinical Trial for Advanced or Metastatic Pancreatic Cancer	Not yet recruiting	2	26	NA	LTC004 + MIL-97, LTC004 + MIL-97+chemotherapy	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Pancreas Cancer	03/29	03/31
NCT06322563: Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC	Not yet recruiting	2	20	RoW	LTC004+regorafenib	Tianjin Medical University Cancer Institute and Hospital	Advanced/Metastatic Colorectal Cancer	03/25	03/25
NCT06490068: Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy	Recruiting	2	10	RoW	LTC004+Toripalimab, LTC004 combine with Toripalimab	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Advanced Solid Tumor	03/26	03/26
NCT06384235: Phase II Clinical Study of LTC004 in Patients With mCRC	Not yet recruiting	1/2	30	NA	LTC004	Letolab	Locally Advanced or Metastatic CRC	08/25	08/25
NCT06384248: Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma	Not yet recruiting	1/2	30	NA	LTC004	Letolab	Unresectable or Metastatic Sarcoma	12/25	12/25
NCT06277804: A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor	Not yet recruiting	1	48	NA	LTC004 in Combination With Cyclophosphamide and Fludarabine	Letolab	Adult Solid Tumor	07/27	07/27
NCT05666635: Study of LTC004 in Subjects With Advanced Malignant Tumors	Not yet recruiting	1	368	NA	LTC004	Letolab	Adult Solid Tumor	12/24	12/24